Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer

NCT06503744 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2026-04-13

No results posted yet for this study

Summary

The aim of this study is to investigate the efficacy and safety of transthoracic versus transbronchial ablation in the treatment of early stage peripheral lung cancer.

Conditions

  • Lung Cancer Stage IA

Interventions

PROCEDURE

ablation

ablation

Sponsors & Collaborators

  • Sir Run Run Shaw Hospital

    collaborator OTHER
  • Beijing Chao Yang Hospital

    collaborator OTHER
  • Shanghai Chest Hospital

    lead OTHER

Principal Investigators

  • Jiayuan Sun, PhD · Shanghai Chest Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-04
Primary Completion
2026-12-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06503744 on ClinicalTrials.gov